Archives for February 16, 2009

← 2009

Transatlantic genetic testing alliance

By Phil Taylor

US firm Expression Analysis has teamed up with Complement Genomics of the UK to combine their genetic testing service offerings.

Myozyme becomes Lumizyme after biologics scale-up

By Nick Taylor

Genzyme will launch the same biologic under two different names in the US after the FDA decided the drug produced at 2000L was considerably different to the 160L version.

SAFC's Q4 hit by lack of visibility in drug sector

By Gareth Macdonald

SAFC’s fourth quarter performance was hurt by dip in demand from big pharma in the US and Europe combined with lower sales to the chemical industry, according to parent company Sigma Aldrich.

Phase Forward tops expectations in Q4

By Phil Taylor

eClinical specialist Phase Forward saw revenues top guidance with a 28 per cent increase to $48m in the fourth quarter of 2008, driven by growth in its InForm electronic data capture (EDC) system.

etrials adds competitor Unithink to confidentiality case

By Gareth Macdonald

US software specialist etrials Worldwide has added Belgian rival Unithink to an ongoing lawsuit that accuses two former executives, Robert Sammis and Brendon Ball, of breaching confidentiality agreements.

Biologics and sterile production boost CMOs

By Nick Taylor

A study is predicting biologics will drive contract manufacturing to new heights, with Gilead Sciences reported to be the latest biotech to pursue production partnerships in India.